Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

BDTXBDTX
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in BLACK DIAMOND THERAPEUTICS I

BANK OF AMERICA CORP /DE/ holds 413,516 shares of BDTX (BLACK DIAMOND THERAPEUTICS I), worth $765,004 as of 2026-Q2. The position was increased (+262.3% shares).

Current Value

$765,004

Current Shares

413,516

Total Value Change

+$605,105

Total Shares Change

+338,797

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
413,516
+262.3%
$765,0040.0%$1.85
27
2026-Q1
Increased
114,143
+123.4%
$243,1250.0%$2.30
25
2025-Q4
Increased
51,103
+17.9%
$124,1800.0%$2.49
18
2025-Q3
Increased
43,359
+22.5%
$164,3300.0%$3.73
19
2025-Q2
Decreased
35,387
-23.2%
$87,7600.0%$2.35
0
2025-Q1
Decreased
46,060
-38.4%
$71,3940.0%$1.61
0
2024-Q4
New
74,719
-
$159,8990.0%$2.15
34

Other major holders of BDTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used